401 related articles for article (PubMed ID: 4353758)
21. Invited discussion: relationship of titers of Epstein-Barr virus to cell-mediated immunity in patients with Hodgkin's disease.
Levine PH; Reisher JI
Natl Cancer Inst Monogr; 1973 May; 36():85-7. PubMed ID: 4355354
[No Abstract] [Full Text] [Related]
22. [Immunology of Epstein-Barr virus in lymphoproliferative diseases].
Bachmann AE; Giraudo Conesa LC; Braun M
Medicina (B Aires); 1974 Mar; 34(2):157-66. PubMed ID: 4368156
[No Abstract] [Full Text] [Related]
23. Epstein-barr-virus nuclear antigen.
Vonka V; Hirsch I
Prog Med Virol; 1982; 28():145-79. PubMed ID: 6283600
[No Abstract] [Full Text] [Related]
24. Burkitt's lymphoma - a human tumor model system for immunological studies.
Gunvén P
Biochim Biophys Acta; 1975 Dec; 417(3-4):187-210. PubMed ID: 175835
[TBL] [Abstract][Full Text] [Related]
25. Epstein-Barr virus-associated membrane-reactive antibodies during long term survival Burkitt's lymphoma.
Gunvén P; Klein G; Clifford P; Singh S
Proc Natl Acad Sci U S A; 1974 Apr; 71(4):1422-6. PubMed ID: 4364538
[TBL] [Abstract][Full Text] [Related]
26. Epstein-Barr virus infections.
Middleton PJ
Can Med Assoc J; 1974 Jan; 110(1):9-10. PubMed ID: 4358535
[No Abstract] [Full Text] [Related]
27. Antibody levels to infectious agents other than Epstein-Barr virus in Burkitt's lymphoma patients.
Morrow RH; Sever JL; Henderson BE
Cancer Res; 1974 May; 34(5):1212-5. PubMed ID: 4366991
[No Abstract] [Full Text] [Related]
28. Association of Epstein-Barr virus and American Burkitt's lymphoma.
Easton JM; Ablashi DV; Levine PH; Armstrong GR
IARC Sci Publ (1971); 1975; (11 Pt 2):37-43. PubMed ID: 191381
[No Abstract] [Full Text] [Related]
29. Seroepidemiological studies on carcinoma of the nasopharynx.
Lin TM; Yang CS; Chiou JF; Tu SM; Lin CC; Liu CH; Chen KP; Ito Y; Kawamura A; Hirayama T
Cancer Res; 1973 Nov; 33(11):2603-8. PubMed ID: 4355974
[No Abstract] [Full Text] [Related]
30. Humoral and cellular immunity to EBV and lymphoid cell line antigens in human lymphoma.
Levine PH; Connelly RR; Herberman RB; McCoy JL; Fabrizio PL
IARC Sci Publ (1971); 1975; (11 Pt 2):225-35. PubMed ID: 191366
[TBL] [Abstract][Full Text] [Related]
31. Epstein-Barr virus, infectious mononucleosis, Burkitt's lymphoma and nasopharyngeal carcinoma.
Klein G
Isr J Med Sci; 1977 Jul; 13(7):716-24. PubMed ID: 200586
[No Abstract] [Full Text] [Related]
32. Antibodies associated with Epstein-Barr virus in Burkitt's lymphoma during injections of BCG or irradiated autochthonous tumor cells.
Gunvén P; Klein G; Onyango J; Henle G; Henle W; Clifford P; Singh S; Demissie A; Svedmyr A
J Natl Cancer Inst; 1973 Jul; 51(1):45-56. PubMed ID: 4352753
[No Abstract] [Full Text] [Related]
33. [Role of the Epstein-Barr virus in human pathology].
Rupniewska ZM
Acta Haematol Pol; 1979; 10(3):183-91. PubMed ID: 228518
[No Abstract] [Full Text] [Related]
34. Evaluation of delayed hypersensitivity reactions to lymphoid cell lines and antibodies to Epstein-Barr virus.
Levine PH; Ho JH; Nkrumah F; Andrese AP
IARC Sci Publ (1971); 1978; (24 Pt 2):893-8. PubMed ID: 221411
[No Abstract] [Full Text] [Related]
35. Specific neutralizing antibodies in Epstein-Barr virus associated diseases.
Rocchi G; Hewetson J; Henle W
Int J Cancer; 1973 May; 11(3):637-47. PubMed ID: 4364719
[No Abstract] [Full Text] [Related]
36. [Immunobiology of Burkitt's lymphoma and human leukemias].
Harlozińska A
Postepy Hig Med Dosw; 1974; 28(3):271-91. PubMed ID: 4136196
[No Abstract] [Full Text] [Related]
37. Epstein-Barr virus in Burkitt's lymphoma and nasopharyngeal carcinoma. Antibodies to EBV associated membrane and viral capsid antigens in Burkitt lymphoma patients.
Gunvén P; Klein G; Henle G; Henle W; Clifford P
Nature; 1970 Dec; 228(5276):1053-6. PubMed ID: 4320656
[No Abstract] [Full Text] [Related]
38. Antibodies to a new antigen induced by Epstein-Barr virus in patients with nasopharyngeal carcinoma, leukemia, malignant lymphoma, and in control groups.
Ida S; Sairenji T; Hinuma Y
Gan; 1972 Feb; 63(1):49-55. PubMed ID: 4339712
[No Abstract] [Full Text] [Related]
39. [Problems posed by the immunological properties common to Burkitt's lymphoma and cancer. Means of resolving them].
De-Thé G
Ann Inst Pasteur (Paris); 1972 Apr; 122(4):767-88. PubMed ID: 4340546
[No Abstract] [Full Text] [Related]
40. Increase in antibody titer against the EBV-associated membrane antigen complex in Burkitt's lymphoma and nasopharyngeal carcinoma after local irradiation.
Einhorn N; Klein G; Clifford P
Cancer; 1970 Nov; 26(5):1013-21. PubMed ID: 4920396
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
